{"log_id": 6029090277685372906, "direction": 0, "words_result_num": 37, "words_result": [{"probability": {"variance": 0.005669, "average": 0.979519, "min": 0.528741}, "location": {"width": 850, "top": 138, "height": 45, "left": 207}, "words": "发生率<1%:一过性、无症状的AST和/或ALT、胆红素升高。主要发生于高催吐化疗的患者"}, {"probability": {"variance": 0, "average": 0.985093, "min": 0.985093}, "location": {"width": 47, "top": 144, "height": 44, "left": 1140}, "words": "品"}, {"probability": {"variance": 0, "average": 0.9996, "min": 0.999557}, "location": {"width": 44, "top": 186, "height": 23, "left": 207}, "words": "代谢"}, {"probability": {"variance": 0, "average": 0.997234, "min": 0.997234}, "location": {"width": 29, "top": 201, "height": 27, "left": 1149}, "words": "证"}, {"probability": {"variance": 0.000216, "average": 0.99538, "min": 0.905736}, "location": {"width": 861, "top": 227, "height": 43, "left": 206}, "words": "发生率1%:高钾血症;发生率<1%:电解质紊乱、高血糖、代谢性酸中毒、尿糖、食欲减"}, {"probability": {"variance": 0, "average": 0.998736, "min": 0.998057}, "location": {"width": 85, "top": 273, "height": 25, "left": 164}, "words": "退和厌食"}, {"probability": {"variance": 2e-06, "average": 0.998601, "min": 0.99564}, "location": {"width": 132, "top": 316, "height": 28, "left": 205}, "words": "骨骼肌肉系统"}, {"probability": {"variance": 0.00051, "average": 0.990085, "min": 0.923422}, "location": {"width": 208, "top": 358, "height": 29, "left": 205}, "words": "发生率<1%:关节痛"}, {"probability": {"variance": 0, "average": 0.9993, "min": 0.998658}, "location": {"width": 89, "top": 401, "height": 27, "left": 204}, "words": "神经系统"}, {"probability": {"variance": 0.014233, "average": 0.947527, "min": 0.587237}, "location": {"width": 650, "top": 445, "height": 34, "left": 203}, "words": "发生率1%:头晕;发生率<1%:失倩绪亢进,感觉异常"}, {"probability": {"variance": 2e-06, "average": 0.998252, "min": 0.995914}, "location": {"width": 88, "top": 488, "height": 26, "left": 204}, "words": "精神系统"}, {"probability": {"variance": 0.001185, "average": 0.95856, "min": 0.910805}, "location": {"width": 138, "top": 476, "height": 34, "left": 573}, "words": "(海南"}, {"probability": {"variance": 0.004616, "average": 0.974464, "min": 0.710681}, "location": {"width": 494, "top": 518, "height": 48, "left": 201}, "words": "发生率1%:焦虑;发生率<1欣快感"}, {"probability": {"variance": 4e-06, "average": 0.998532, "min": 0.995378}, "location": {"width": 90, "top": 573, "height": 28, "left": 201}, "words": "泌尿系统"}, {"probability": {"variance": 0.000725, "average": 0.987667, "min": 0.909191}, "location": {"width": 210, "top": 617, "height": 28, "left": 201}, "words": "发生率<1%:尿潴留"}, {"probability": {"variance": 1e-06, "average": 0.998892, "min": 0.997877}, "location": {"width": 92, "top": 661, "height": 25, "left": 197}, "words": "血管系统"}, {"probability": {"variance": 1.4e-05, "average": 0.998425, "min": 0.984545}, "location": {"width": 339, "top": 702, "height": 34, "left": 200}, "words": "发生率<1%:静脉变色、静脉扩张"}, {"probability": {"variance": 1e-06, "average": 0.999296, "min": 0.997716}, "location": {"width": 73, "top": 746, "height": 27, "left": 166}, "words": "【禁忌】"}, {"probability": {"variance": 0.000136, "average": 0.994669, "min": 0.952428}, "location": {"width": 474, "top": 789, "height": 33, "left": 199}, "words": "禁用于已知对该药物或药物中任何组份过敏的患者"}, {"probability": {"variance": 1e-06, "average": 0.999369, "min": 0.997232}, "location": {"width": 114, "top": 833, "height": 25, "left": 165}, "words": "【注意事项】"}, {"probability": {"variance": 0.007211, "average": 0.975868, "min": 0.567112}, "location": {"width": 552, "top": 873, "height": 34, "left": 203}, "words": "过敏反应可能发生于对其它选择性5-HT受体拮抗剂过敏者"}, {"probability": {"variance": 0.001066, "average": 0.993073, "min": 0.78748}, "location": {"width": 852, "top": 913, "height": 42, "left": 198}, "words": "在国外临床试验所研究的剂量水平下,帕洛诺司琼未观察到引起有临床意义的QTc间期延长"}, {"probability": {"variance": 4.5e-05, "average": 0.997293, "min": 0.958715}, "location": {"width": 904, "top": 956, "height": 41, "left": 154}, "words": "在221例健康成年男性和女性志愿者中进行的一项双盲、随机、平行、安慰剂对照和阳性对照(莫"}, {"probability": {"variance": 0.003628, "average": 0.986829, "min": 0.58151}, "location": {"width": 871, "top": 998, "height": 42, "left": 155}, "words": "西沙星)的完整的QT/QTc研究中,评估了帕洛诺司琼对QTc间期的影响。结果显示在0.25mg"}, {"probability": {"variance": 8.1e-05, "average": 0.995249, "min": 0.952528}, "location": {"width": 902, "top": 1042, "height": 39, "left": 154}, "words": "075mg、2.25mg剂量下均未观察到对QTc间期以及其它ECG的影响,也未观察到对心率、房室传"}, {"probability": {"variance": 0.00383, "average": 0.986165, "min": 0.591383}, "location": {"width": 897, "top": 1083, "height": 42, "left": 154}, "words": "导和心脏复极化有临床意义的改变。但是基于其它5一HT受体拮抗剂使用信息,对于伴随使用延"}, {"probability": {"variance": 0.002154, "average": 0.990544, "min": 0.691285}, "location": {"width": 896, "top": 1126, "height": 41, "left": 152}, "words": "长QT间期药物,以及患有或可能发展为QT间期延长的病人,应谨慎使用帕洛诺司琼。这些患者"}, {"probability": {"variance": 5.4e-05, "average": 0.996978, "min": 0.951666}, "location": {"width": 901, "top": 1169, "height": 41, "left": 152}, "words": "包括:低钾血症或低镁血症者、服用利尿药而导致电解质异常者、先天性QT综合症患者、服用抗"}, {"probability": {"variance": 0.004887, "average": 0.981894, "min": 0.572056}, "location": {"width": 799, "top": 1212, "height": 39, "left": 153}, "words": "心律失常或其它药物可导致QT间期延长的患者,和给予累计高剂量葸环类药物治疗者"}, {"probability": {"variance": 3e-06, "average": 0.998643, "min": 0.992155}, "location": {"width": 859, "top": 1266, "height": 38, "left": 193}, "words": "盐酸帕洛诺司琼注射液不能与其他药物混合,故使用帕洛诺司琼注射液前、后均需应用生理"}, {"probability": {"variance": 8e-06, "average": 0.997855, "min": 0.991703}, "location": {"width": 173, "top": 1315, "height": 27, "left": 151}, "words": "盐水冲洗输注管路"}, {"probability": {"variance": 5e-06, "average": 0.998305, "min": 0.99269}, "location": {"width": 249, "top": 1353, "height": 29, "left": 199}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 6.7e-05, "average": 0.99654, "min": 0.949619}, "location": {"width": 852, "top": 1394, "height": 42, "left": 198}, "words": "尚未在妊娠妇女中进行充分的随机对照临床试验,也没有妊娠期或分娩期妇女使用过帕洛诺"}, {"probability": {"variance": 1.9e-05, "average": 0.99741, "min": 0.981039}, "location": {"width": 663, "top": 1437, "height": 38, "left": 150}, "words": "司琼,因此对其对母亲及胎儿的影响并不清楚,故怀孕期间应慎用本品"}, {"probability": {"variance": 4e-06, "average": 0.998483, "min": 0.989629}, "location": {"width": 852, "top": 1480, "height": 44, "left": 197}, "words": "帕洛诺司琼是否通过乳汁分泌尚不明确。鉴于多数药物均经人体乳汁排泄,对乳儿有潜在的"}, {"probability": {"variance": 1.2e-05, "average": 0.997824, "min": 0.983684}, "location": {"width": 899, "top": 1524, "height": 44, "left": 148}, "words": "严重不良反应,且在大鼠致癌作用研究发现有潜在致癌作用。因此,应充分考虑使用药物的必要"}, {"probability": {"variance": 1.5e-05, "average": 0.998198, "min": 0.982842}, "location": {"width": 390, "top": 1568, "height": 35, "left": 148}, "words": "性之后,来决定是否停止哺乳或停止用药"}], "language": 3}